Thomas Ertveldt

Currently, i'm employed as a PhD-Candidate at the "Laboratory for Molecular and Cellular Therapy" (LMCT) researchgroup at the Vrije Universiteit Brussel. My work entails a jointproject between the LMCT and the "in Vivo Cellular and Molecular Imaging" (ICMI) researchgroups in which I’m investigating the immunogenic properties of targeted radionuclide therapy (TRT) mediated by single domain antibodies (sdAb’s).